Patrizia Mondello, MD, PhD, MSc - Memorial Sloan Kettering Cancer Center - Advanced Oncology Fellow

Patrizia Mondello

MD, PhD, MSc

Memorial Sloan Kettering Cancer Center

Advanced Oncology Fellow

New York, New York | United States

Main Specialties: Hematology & Oncology

Additional Specialties: Lymphomas

ORCID logohttps://orcid.org/0000-0002-0355-3757

Patrizia Mondello, MD, PhD, MSc - Memorial Sloan Kettering Cancer Center - Advanced Oncology Fellow

Patrizia Mondello

MD, PhD, MSc

Introduction

Primary Affiliation: Memorial Sloan Kettering Cancer Center - New York, New York , United States

Specialties:

Additional Specialties:

Research Interests:

Education

Jul 2019
Memorial Sloan Kettering Cancer Center
Advanced Oncology Fellow
Lymphoma
Jun 2018
Weill Cornell Medicine
Research Associate
Medicine
Nov 2017
University of Messina
PhD
Applied Biology and Experimental Medicine
Dec 2016
Memorial Sloan Kettering Cancer Center
Research Associate
Medicine
May 2014
Salesian Pontificial University, Faculty of Theology Rome
Master of Science
Bioethics and Sexology
Jul 2009
University of Messina
MD
Medicine

Experience

Dec 2019
ASH Abstract Achievement Award
Award
American Society of Hematology
Aug 2017
Helmsley Scholarship
Scholarship
NCI
Dec 2016
ASH Abstract Achievement Award
Award
American Society of Hematology
May 2015
University of Messina
Board
Medical Oncology
May 2011
Translational research in Haemato-Oncology
Scholarship
Aug 2008
Commonwealth Virginia University
Scholarship
Pediatric Hematology/Oncology

Publications

45Publications

1065Reads

85Profile Views

BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors.

Cell Rep 2018 08;24(8):2155-2166

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22111247183115
Publisher Site
http://dx.doi.org/10.1016/j.celrep.2018.07.055DOI Listing
August 2018
35 Reads
7.207 Impact Factor

Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression.

Oncotarget 2017 Mar;8(12):20394-20409

Department of Hematology and Center of Bone Marrow Transplantation, Hospital of Bolzano, Bolzano/Bozen, Italy.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/14610
Publisher Site
http://dx.doi.org/10.18632/oncotarget.14610DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386771PMC
March 2017
7 Reads
6.359 Impact Factor

An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules.

Oncoimmunology 2017 7;6(2):e1252895. Epub 2016 Dec 7.

Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1252895DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353933PMC
December 2016
52 Reads
6.283 Impact Factor

Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience.

Leuk Lymphoma 2016 10 27;57(10):2429-31. Epub 2016 Jan 27.

f Department of Cellular Biotechnologies and Hematology , Sapienza University , Rome , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1137293DOI Listing
October 2016
10 Reads

Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?

Oncologist 2016 09 5;21(9):1107-12. Epub 2016 Jul 5.

Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria Department of Hematology and Center for Bone Marrow Transplantation, Ospedale di Bolzano, Bolzano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016065PMC
September 2016
42 Reads
4.865 Impact Factor

Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study.

Ann Hematol 2016 Jun 22;95(7):1107-14. Epub 2016 Apr 22.

Internal Medicine V: Hematology & Oncology, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2668-0DOI Listing
June 2016
63 Reads
2.634 Impact Factor

Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?

Anticancer Res 2016 Mar;36(3):1059-65

Department of Medicine, Hematology and Clinical Immunology, Padua University School of Medicine, Padua, Italy.

View Article

Download full-text PDF

Source
March 2016
63 Reads
1.872 Impact Factor

90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityr.

Oncotarget 2016 Feb;7(7):7597-609

Department of Hematology, Hospital S. Maurizio, Bolzano/Bozen, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.6531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884941PMC
February 2016
24 Reads
6.359 Impact Factor

90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward?

Clin Lymphoma Myeloma Leuk 2016 Feb 21;16(2):82-8. Epub 2015 Nov 21.

Universitätsklinik für Innere Medizin V, Hämatologie & Onkologie, Innsbruck, Austria; Department of Hematology and CBMT, Bolzano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.11.014DOI Listing
February 2016
44 Reads

Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent.

Exp Hematol Oncol 2015 6;5. Epub 2016 Jan 6.

Department of Hematology and CBMT, Ospedale di Bolzano, Bolzano, Italy ; Universitätsklinik für Innere Medizin V, Hämatologie and Onkologie, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40164-015-0030-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702294PMC
January 2016
27 Reads

Routine Use of Bendamustine in Patients with Chronic Lymphocytic Leukemia: An Observational Study.

Anticancer Res 2015 Sep;35(9):5129-39

Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
September 2015
15 Reads
1.872 Impact Factor

Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options.

Nutr Cancer 2015 16;67(1):12-26. Epub 2014 Dec 16.

a Department of Human Pathology , University of Messina , Messina , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01635581.2015.976318DOI Listing
September 2015
21 Reads
2.322 Impact Factor

Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?

Acta Oncol 2015 Jun 1;54(6):953-5. Epub 2015 Apr 1.

Department of Human Pathology, University of Messina , Messina , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2015.1027410DOI Listing
June 2015
12 Reads
2.997 Impact Factor

Thyroid function, autoimmunity and nodules in hematological malignancies.

Arch Endocrinol Metab 2015 Jun;59(3):236-44

Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1590/2359-3997000000044DOI Listing
June 2015
31 Reads

Should the use of surveillance imaging in diffuse large B-cell lymphoma be discontinued?

J Clin Oncol 2015 May 23;33(14):1623. Epub 2015 Mar 23.

University of Messina, Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.0627DOI Listing
May 2015
2 Reads
18.428 Impact Factor

Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial.

Ann Hematol 2015 Apr 13;94(4):593-601. Epub 2014 Nov 13.

Department of Internal Medicine V (Haematology and Oncology), Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2250-6DOI Listing
April 2015
54 Reads
2.634 Impact Factor

Emerging drugs for diffuse large B-cell lymphoma.

Expert Rev Anticancer Ther 2015 Apr 5;15(4):439-51. Epub 2015 Feb 5.

Department of Human Pathology, University of Messina, Via C. Valeria, 98100 Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2015.1009042DOI Listing
April 2015
12 Reads
2.249 Impact Factor

Complications of trauma patients admitted to the ICU in level I academic trauma centers in the United States.

Biomed Res Int 2014 3;2014:473419. Epub 2014 Jun 3.

University of South Florida and Trauma Services, Ocala Regional Medical Center, Ocala, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/473419DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065752PMC
February 2015
5 Reads

Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation.

Clin Exp Med 2015 Feb 28;15(1):97-105. Epub 2014 Jan 28.

Department of Internal Medicine, University of Messina, Via Consolare Valeria, 1, 98124, Messina, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10238-014-0272-yDOI Listing
February 2015
13 Reads
2.824 Impact Factor

Circulating mitotic figures in a patient with dual infection by Epstein-Barr virus and cytomegalovirus.

Eur J Haematol 2015 Jan 28;94(1):89. Epub 2013 Jun 28.

Department of Medical Oncology, University of Messina, Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12132DOI Listing
January 2015
5 Reads
2.066 Impact Factor

Pim kinases in hematological malignancies: where are we now and where are we going?

J Hematol Oncol 2014 Dec 10;7:95. Epub 2014 Dec 10.

Department of Hematology, Hospital S. Maurizio, Bolzano/Bozen, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-014-0095-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266197PMC
December 2014
22 Reads
4.812 Impact Factor

Radiotherapy for stage I/II follicular lymphoma (FL): is it time for a re-appraisal?

Anticancer Res 2014 Nov;34(11):6701-4

Department of Hematology & Oncology, Medical University of Innsbruck, Innsbruck, Austria Department of Hematology, Azienda Ospedaliera S. Maurizio, Bolzano, Italy.

View Article

Download full-text PDF

Source
November 2014
26 Reads
1.872 Impact Factor

Emerging markers of cachexia predict survival in cancer patients.

BMC Cancer 2014 Nov 16;14:828. Epub 2014 Nov 16.

Department of Human Pathology, University of Messina, Via Consolare Valeria, 98125 Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-828DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239407PMC
November 2014
54 Reads
3.362 Impact Factor

90Y-Ibritumomab Tiuxetan consolidation after autologous stem cell transplantation improves survival of patients with intermediate-/high-risk diffuse large B-cell lymphoma not responding adequately to first-line treatment.

Anticancer Res 2014 Sep;34(9):5121-5

Department of Hematology, Hospital S. Maurizio, Bolzano/Bozen, Italy Department of Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
September 2014
4 Reads
1.872 Impact Factor

Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia.

Lung Cancer 2013 Oct 9;82(1):171-2. Epub 2013 Aug 9.

Department of Medical Oncology, University of Messina, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.07.004DOI Listing
October 2013
10 Reads
3.958 Impact Factor

Questionable validity of cardiac risk score on the basis of the NSABP B-31 model.

J Clin Oncol 2013 Jun 6;31(17):2224. Epub 2013 May 6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.2696DOI Listing
June 2013
5 Reads
18.428 Impact Factor

Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma.

Case Rep Hematol 2012 26;2012:803298. Epub 2012 Dec 26.

Department of Medical Oncology (Pad. H 5° Piano), University of Messina, Via Consolare Valeria Road 98125 Messina, Italy.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/crihem/2012/803298/
Publisher Site
http://dx.doi.org/10.1155/2012/803298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541567PMC
January 2013
7 Reads

Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.

Shock 2012 Oct;38(4):356-66

Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SHK.0b013e318267bbb9DOI Listing
October 2012
11 Reads
3.045 Impact Factor

Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: a comparison with n-acetylcysteine.

Eur J Pharmacol 2012 Jan 9;674(2-3):397-406. Epub 2011 Nov 9.

Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2011.10.041DOI Listing
January 2012
6 Reads
2.532 Impact Factor

Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats.

Naunyn Schmiedebergs Arch Pharmacol 2011 May 11;383(5):493-508. Epub 2011 Mar 11.

Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Centro Neurolesi Bonino-Pulejo, Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00210-011-0610-5DOI Listing
May 2011
19 Reads
2.471 Impact Factor

Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice.

Eur J Pharmacol 2011 May 22;658(1):28-40. Epub 2011 Feb 22.

Department of Internal Medicine, University of Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2011.02.008DOI Listing
May 2011
3 Reads
2.532 Impact Factor

Glutamine treatment attenuates the development of ischaemia/reperfusion injury of the gut.

Eur J Pharmacol 2010 Sep 3;643(2-3):304-15. Epub 2010 Jul 3.

Department of Internal Medicine, University of Messina, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00142999100063
Publisher Site
http://dx.doi.org/10.1016/j.ejphar.2010.06.044DOI Listing
September 2010
4 Reads
2.532 Impact Factor

Glutamine-supplemented total parenteral nutrition improves immunological status in anorectic patients.

Nutrition 2010 Jun 1;26(6):677-81. Epub 2010 Feb 1.

Department of Internal Medicine, Messina University Hospital, School of Medicine, University of Messina, Messina, Italy.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S089990070900432
Publisher Site
http://dx.doi.org/10.1016/j.nut.2009.10.008DOI Listing
June 2010
2 Reads
2.926 Impact Factor

Role of prostaglandin E2 in the invasiveness, growth and protection of cancer cells in malignant pleuritis.

Eur J Cancer 2006 Sep 8;42(14):2382-9. Epub 2006 Aug 8.

Istituto di Biomedicina e Immunologia Molecolare, Consiglio Nazionale delle Ricerche, Via Ugo La Malfa, 153, 90146 Palermo, Italy.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980490600505
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2006.03.022DOI Listing
September 2006
12 Reads
5.417 Impact Factor

Top co-authors

Vincenzo Pitini
Vincenzo Pitini

University of Messina

18
Michael Mian
Michael Mian

Oncology Institute of Southern Switzerland (IOSI)

18
Salvatore Cuzzocrea
Salvatore Cuzzocrea

University of Messina

14
Carmela Aloisi
Carmela Aloisi

University of Messina

9
Giuseppe Altavilla
Giuseppe Altavilla

University of Messina

8
Anas Younes
Anas Younes

Memorial Sloan Kettering Cancer Center

6
Domenico Italiano
Domenico Italiano

University of Messina

5
David A Scheinberg
David A Scheinberg

Sloan-Kettering Institute

5